- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- 3 Hot Mid-Cap Stock Picks: Portfolio Manager
- 'Nice Opportunities' in Health Care Sector: Stock Picker
- Stocks To Play With Health Reform: Analysts
- 4 Tech Stocks For This Holiday Season: Analyst
- Art Cashin: I'm Still Skeptical About Markets
- Rockwell Automation Earnings: What Options Are Saying
- Gold Will Touch Higher Lows and Higher Highs: Analyst
- Correction Coming When Fed Ends 'Easy Money': Market Pro
MOST SHARED
- Future of Marketing
- Obama Says Will Raise Currency Issue with China
- Can Apple Top Microsoft as Most Valuable Tech Firm?
- Priceline Crushes Profit Forecasts; Shares Jump
- Oil Tomorrow
- Dow Up Over 100 After G20 Stimulus Pledge
- Maria's Market Message
- Trial of Ex-Bear Stearns Managers Goes to Jury
- Investors Should Limit Exposure to US Equities: Gross
- Why Google is Paying $750 Million for Ad Mob
- Warren Buffett to Sell Stakes In Union Pacific & Norfolk Southern
- Nov. 9: Unusual Volume Leaders
- The Battered Businesses Behind Housing
- Modern Warfare 2's Record-Breaking Launch
- Merck’s Mega-Monday Morning
- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- S&P Stocks Trading at New 52-Week Highs
- Look Ahead: 'Risk On' Attitude Could Fuel Rally Further
- European Commission Objects to Sun Micro-Oracle Deal
- Obama Sees Strains Unless US, China Balance Growth
- Can Apple Top Microsoft as Most Valuable Tech Firm?
- Buffett to Sell Stakes in Norfolk Southern, Union Pacific
- Cramer: 5 Stocks to Play the Next Bull Run
- Do You Know Your Coca-Cola Myths?
- Electronic Arts Beats Street, Announces 1,500 Job Cuts
- Time Is Here to Look at Overseas Stocks: Bill Gross
RSS FEED
CNBC Stock Blog
Text Size 
Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.
“Health care is a good place to be,” said Manley. “Biotech [stocks] are cheap, and some of the big pharmaceutical companies have done nothing good for eight years. [Although] there’s a general fear that you don’t want to own any stocks before an election, when I see a consensus that rock-hard, I think there may be an opposite side to it.”
Wood, however, disagreed with Manley.
“I’m not as convinced with the election trade as a lot of people are,” he said. “I’m waiting for a lot of specifics from both candidates, but making big bets based on an election year may not be a good idea.”
Disclosures:
Disclosure information for Stephen Wood and John Manley were not immediately available.
_________________________________
Top biotech names:
Biogen Idec [BIIB
Loading...
()
]
Genentech [DNA
Loading...
()
]
Amgen [AMGN
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Celgene [CELG
Loading...
()
]
_________________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes